Hi @chikspat
Challenges:
Management acknowledges potential earnings dips post-Revlimid patent expiry, emphasizing the need for new product launches to offset declines.
Does any one know the expiry details of the Revlimid patent expiry? if you do know pls share.
| Subscribe To Our Free Newsletter |
